Click HERE for Coronavirus COVID-19 Links for the UCSF Cancer Community

An Estrogen Receptor that Promotes Cancer also Causes Drug Resistance

UCSF Researchers Discover New Role for Erα as an RNA-Binding Protein

Ana Velázquez Mañana, MD, ASCO Mentor for Oncology Student Diversity

This summer, Ana Velázquez Mañana, MD, fellow in Medical Oncology, led UCSF’s first class of medical students from groups underrepresented in medicine.

HDFCCC Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

The Helen Diller Family Comprehensive Cancer Center (HDFCCC) at UCSF was invited to participate in a national Pilot Project testing a research site self-assessment tool focused on increasing racial and ethnic diversity among cancer treatment trial participants.

Cancer Center BOP Members May Boycott Conference over Texas Abortion Law

In response to the recent adoption of the Texas Heartbeat Act (SB8) banning nearly all abortions, the Cancer Center’s Breast Oncology Program members are part of a growing effort to move the annual San Antonio Breast Cancer Symposium (SABCS) out of Texas.

Umoja Health Celebrates First Anniversary

Organizers Celebrate 3000 Vaccinations and a Proclamation from Oakland Mayor Libby Schaff

NCI Names Fong Outstanding Investigator

When Larry Fong, MD, started his career in medicine, immunotherapy was considered science fiction. Today, immunotherapy is a key frontier in cancer treatment, and Fong, a recognized leader in the field, holds one of the NCI’s most competitive awards.

Science and medicine have embraced Twitter. Should you?

Twitter’s reach and ability to influence have made it a critical communication tool in all areas of life and work. Learn how UCSF cancer experts are harnessing the value of Twitter's bite-sized benefits.

HDFCCC Pledges Funds for Bold, Provocative Ideas

Cancer Center leadership is calling on members to submit their boldest ideas for future research projects and collaborations that will drive funding priorities and scientific emphasis over the coming decade.

Cell Bots courtesy Wendell Lim Lab, UCSF

Beyond CAR-T: New Frontiers in Living Cell Therapies

The idea of using cells as medicine emerged with bone marrow transplants, and then CAR-T therapy for blood cancers. Now, scientists are beginning to engineer much more complex living therapeutics by tapping into the innate capabilities of living cells to treat a growing list of diseases.